CoChat

Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing

Open access
Lane, Dan, Lawson, Alexander, Burns, Angela, Azizi, Michel, Burnier, Michel, Jones, Donald J.L., Kably, Benjamin, Khunti, Kamlesh, Kreutz, Reinhold, Patel, Prashanth, Persu, Alexandre, Spiering, Wilko, Toennes, Stefan W., Tomaszewski, Maciej, Williams, Bryan, Gupta, Pankaj, Dasgupta, Indranil, Endorsed by the European Society of Hypertension (ESH) Working Group on Cardiovascular Pharmacotherapy and Adherence · 2022 · Hypertension
Cited by 111

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Nonadherence to antihypertensive medication is common, especially in those with apparent treatment-resistant hypertension (true treatment-resistant hypertension requires exclusion of nonadherence), and its routine detection is supported by clinical guidelines. Chemical adherence testing is a reliable and valid method to detect adherence, yet methods are unstandardized and are not ubiquitous. This article describes the principles of chemical adherence testing for hypertensive patients and provides a set of recommendations for centers wishing to develop the test. We recommend testing should be done in either of two instances: (1) in those who have resistant hypertension or (2) in those on 2 antihypertensives who have a less than 10 mm Hg drop in systolic blood pressure on addition of the second antihypertensive medication. Furthermore, we recommend that verbal consent is secured before undertaking the test, and the results should be discussed with the patient. Based on medications prescribed in United Kingdom, European Union, and United States, we list top 20 to 24 drugs that cover >95% of hypertension prescriptions which may be included in the testing panel. Information required to identify these medications on mass spectrometry platforms is likewise provided. We discuss issues related to ethics, sample collection, transport, stability, urine versus blood samples, qualitative versus quantitative testing, pharmacokinetics, instrumentation, validation, quality assurance, and gaps in knowledge. We consider how to best present, interpret, and discuss chemical adherence test results with the patient. In summary, this guidance should help clinicians and their laboratories in the development of chemical adherence testing of prescribed antihypertensive drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.121.17596

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 111

Metadata

Authors
Lane, D., Lawson, A., Burns, A., Azizi, M., Burnier, M., Jones, D. J. L., Kably, B., Khunti, K., Kreutz, R., Patel, P., Persu, A., Spiering, W., Toennes, S. W., Tomaszewski, M., Williams, B., Gupta, P., Dasgupta, I., & Endorsed by the European Society of Hypertension (ESH) Working Group on Cardiovascular Pharmacotherapy and Adherence
Venue
Hypertension
Published
2022-01
Volume
79
Issue
1
Pages
12-23
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W3208220511
Cited by
111
References
11
FWCI
19.27
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing. https://app.cochat.ai/papers/10.1161/hypertensionaha.121.17596
The paper
Lane, D., Lawson, A., Burns, A., Azizi, M., Burnier, M., Jones, D. J. L., Kably, B., Khunti, K., Kreutz, R., Patel, P., Persu, A., Spiering, W., Toennes, S. W., Tomaszewski, M., Williams, B., Gupta, P., Dasgupta, I., & Endorsed by the European Society of Hypertension (ESH) Working Group on Cardiovascular Pharmacotherapy and Adherence. (2022). Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing. Hypertension. https://doi.org/10.1161/hypertensionaha.121.17596

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.